Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peter Rijnbeek

Showing results (21-30 of 52) with videos related to

Pageof 6
Sort By:
Infection|April 2, 2015
Antibiotic use varies substantially among adults: a cross-national study from five European Countries in the ARITMO projectAnil Mor, Trine Frøslev, Reimar Wernich Thomsen, et al.
Drug Safety|March 28, 2023
Impact of European Union Label Changes for Fluoroquinolone-Containing Medicinal Products for Systemic and Inhalation Use: Post-Referral Prescribing TrendsNelly F Ly, Clare Flach, Thom S Lysen, et al.
BMC Medicine|May 21, 2019
Risks and clinical predictors of cirrhosis and hepatocellular carcinoma diagnoses in adults with diagnosed NAFLD: real-world study of 18 million patients in four European cohortsMyriam Alexander, A Katrina Loomis, Johan van der Lei, et al.
CMAJ : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne|April 20, 2017
Use of azithromycin and risk of ventricular arrhythmiaGianluca Trifirò, Maria de Ridder, Janet Sultana, et al.
The Journal of Allergy and Clinical Immunology. in Practice|April 10, 2022
Characterization of Asthma by Age of Onset: A Multi-Database Cohort StudyEsmé J Baan, Emmely W de Roos, Marjolein Engelkes, et al.
Studies in Health Technology and Informatics|January 25, 2024
Health-Analytics Data to Evidence Suite (HADES): Open-Source Software for Observational ResearchMartijn Schuemie, Jenna Reps, Adam Black, et al.
Pharmacoepidemiology and Drug Safety|October 9, 2025
Recommendations to Enable Broader Use of Real-World Evidence to Inform Decision-Making Throughout Pharmacovigilance Signal ManagementG Niklas Norén, Katherine Donegan, Monica A Muñoz, et al.
Journal of Neural Transmission (Vienna, Austria : 1996)|September 19, 2014
Effectiveness of risk minimization measures for cabergoline-induced cardiac valve fibrosis in clinical practice in ItalyDomenico Italiano, Elisa Bianchini, Maura Ilardi, et al.
Pharmacoepidemiology and Drug Safety|October 25, 2023
IncidencePrevalence: An R package to calculate population-level incidence rates and prevalence using the OMOP common data modelBerta Raventós, Martí Català, Mike Du, et al.
EGEMS (Washington, DC)|March 26, 2016
Data Extraction and Management in Networks of Observational Health Care Databases for Scientific Research: A Comparison of EU-ADR, OMOP, Mini-Sentinel and MATRICE StrategiesRosa Gini, Martijn Schuemie, Jeffrey Brown, et al.
Pageof 6

Showing results (21-30 of 52) with videos related to

Sort By:
Pageof 6
Infection|April 2, 2015
Antibiotic use varies substantially among adults: a cross-national study from five European Countries in the ARITMO projectAnil Mor, Trine Frøslev, Reimar Wernich Thomsen, et al.
Drug Safety|March 28, 2023
Impact of European Union Label Changes for Fluoroquinolone-Containing Medicinal Products for Systemic and Inhalation Use: Post-Referral Prescribing TrendsNelly F Ly, Clare Flach, Thom S Lysen, et al.
BMC Medicine|May 21, 2019
Risks and clinical predictors of cirrhosis and hepatocellular carcinoma diagnoses in adults with diagnosed NAFLD: real-world study of 18 million patients in four European cohortsMyriam Alexander, A Katrina Loomis, Johan van der Lei, et al.
CMAJ : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne|April 20, 2017
Use of azithromycin and risk of ventricular arrhythmiaGianluca Trifirò, Maria de Ridder, Janet Sultana, et al.
The Journal of Allergy and Clinical Immunology. in Practice|April 10, 2022
Characterization of Asthma by Age of Onset: A Multi-Database Cohort StudyEsmé J Baan, Emmely W de Roos, Marjolein Engelkes, et al.
Studies in Health Technology and Informatics|January 25, 2024
Health-Analytics Data to Evidence Suite (HADES): Open-Source Software for Observational ResearchMartijn Schuemie, Jenna Reps, Adam Black, et al.
Pharmacoepidemiology and Drug Safety|October 9, 2025
Recommendations to Enable Broader Use of Real-World Evidence to Inform Decision-Making Throughout Pharmacovigilance Signal ManagementG Niklas Norén, Katherine Donegan, Monica A Muñoz, et al.
Journal of Neural Transmission (Vienna, Austria : 1996)|September 19, 2014
Effectiveness of risk minimization measures for cabergoline-induced cardiac valve fibrosis in clinical practice in ItalyDomenico Italiano, Elisa Bianchini, Maura Ilardi, et al.
Pharmacoepidemiology and Drug Safety|October 25, 2023
IncidencePrevalence: An R package to calculate population-level incidence rates and prevalence using the OMOP common data modelBerta Raventós, Martí Català, Mike Du, et al.
EGEMS (Washington, DC)|March 26, 2016
Data Extraction and Management in Networks of Observational Health Care Databases for Scientific Research: A Comparison of EU-ADR, OMOP, Mini-Sentinel and MATRICE StrategiesRosa Gini, Martijn Schuemie, Jeffrey Brown, et al.
Pageof 6